Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribavirin dosing regimen pharmacokinetics study in chronic hepatitis C
2006-003404-19Phase 2Active
- Sponsor
- NUTRIM
- Start
- Apr 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of ribavirin in chronic hepatitis C (CHC) (2 arms), sponsored by NUTRIM. Started Apr 2007; status: active.
02
Drugs
ribavirin
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on 2006-003404-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003404-19.